AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
tylosin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, produced by Streptomyces strains | 5642 | 1401-69-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans
|
Drug dosage:
None
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| CHEBI has role | CHEBI:35703 | xenobiotic |
| CHEBI has role | CHEBI:50904 | allergen |
| CHEBI has role | CHEBI:76969 | bacterial metabolite |
| CHEBI has role | CHEBI:78298 | environmental contaminant |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | Bovine respiratory complex associated with Pasteurella multocida | Indication |
| Cattle | Necrotic pododermatitis (foot rot) caused by Fusobacterium necrophorum | Indication |
| Cattle | Metritis caused by Arcanobacterium pyogenes | Indication |
| Cattle | To reduce incidence of liver abscesses associated with Fusobacterium necrophorum | Indication |
| Cattle | Bovine respiratory complex associated with Arcanobacterium pyogenes | Indication |
| Cattle | Calf diphtheria caused by Fusobacterium necrophorum | Indication |
| Cattle | To reduce incidence of liver abscesses associated with Arcanobacterium pyogenes | Indication |
| Chickens | To control mortality caused by necrotic enteritis (NE) associated with Clostridium perfringens | Indication |
| Chickens | Air sacculitis (air-sac disease chronic respiratory disease) caused by Mycoplasma gallisepticum | Indication |
| Chickens | CRD associated with Mycoplasma gallisepticum | Indication |
| Chickens | CRD associated with Mycoplasma synoviae | Indication |
| Honey Bees | To control American Foulbrood (Paenibacillus larvae) | Indication |
| Swine | To treat swine arthritis caused by Mycoplasma hyosynoviae | Indication |
| Swine | Swine pneumonia caused by Pasteurella spp | Indication |
| Swine | Swine erysipelas caused by rhusiopathiae | Indication |
| Swine | Swine dysentery associated with Treponema hyodysenteriae | Indication |
| Swine | Swine dysentery associated with B hyodysenteriae | Indication |
| Swine | Atrophic rhinitis | Indication |
| Swine | Proliferative enteropathies (PPE, ileitis) associated with L intracellularis | Indication |
| Turkeys | Infectious sinusitis associated with Mycoplasma gallisepticum | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Tylan 10, Tylan 40, Tylan 100, Tylan 100 CAL | Elanco US Inc. | 1 |
| Tylan 200 Injection, Tylan 50 Injection | Elanco US Inc. | 1 |
| Tylan Soluble | Elanco US Inc. | 1 |
| Tylan 5 Sulfa-G, Tylan 10 Sulfa-G, Tylan 20 Sulfa-G, Tylan 40 Sulfa-G | Elanco US Inc. | 2 |
| Tylan 40 | Zoetis Inc. | 1 |
| Tylan 10 Sulfa-G, Tylan 40 Sulfa-G | Zoetis Inc. | 2 |
| TYLAN 20, TYLAN 40 | Phibro Animal Health Corp. | 1 |
| Rumensin and Tylan | Elanco US Inc. | 2 |
| Tylan and Banminth | Phibro Animal Health Corp. | 2 |
| Component E-C with Tylan, Component E-S with Tylan | Elanco US Inc. | 3 |
| Component E-H with Tylan | Elanco US Inc. | 3 |
| MGA and Rumensin and Tylan | Zoetis Inc. | 3 |
| Tylosin Injection | Huvepharma EOOD | 1 |
| MGA and Bovatec and Tylan | Zoetis Inc. | 3 |
| MGA and Tylan | Zoetis Inc. | 2 |
| MGA and Tylan | Zoetis Inc. | 2 |
| Deccox and Rumensin and Tylan | Zoetis Inc. | 3 |
| Paylean/Tylan | Elanco US Inc. | 2 |
| Optaflexx and Rumensin and Tylan | Elanco US Inc. | 3 |
| Optaflexx and Rumensin and Tylanand MGA | Elanco US Inc. | 4 |
| Zilmax and Rumensin and Tylan | Intervet Inc. | 3 |
| Zilmax and Rumensin and Tylan and MGA | Intervet Inc. | 4 |
| Experior and Rumensin and Tylan | Elanco US Inc. | 3 |
| Component TE-G, Component TE-G with Tylan, Component TE-ID with Tylan, Component TE-IS, Component TE-IS with Tylan, Component TE-S, Component TE-S with Tylan | Elanco US Inc. | 3 |
| Component T-H with Tylan, Component T-S with Tylan | Elanco US Inc. | 2 |
| Component TE-200 with Tylan, Component TE-H with Tylan, Component TE-IH with Tylan | Elanco US Inc. | 3 |
| HeifermaX 500 / Rumensin / Tylan | Elanco US Inc. | 3 |
| Heifermax / Optaflexx / Rumensin / Tylan | Elanco US Inc. | 4 |
| Heifermax 500 Liquid Premix and Tylan | Elanco US Inc. | 2 |
| HeifermaX 500 plus Bovatec and Tylan | Elanco US Inc. | 3 |
| BiloVet | Bimeda Animal Health Limited | 1 |
| Tylovet Soluble | Huvepharma EOOD | 1 |
| Heifermax 500/Zilmax/Rumensin/Tylan | Elanco US Inc. | 4 |
| Tylovet 40, Tylovet 100 | Huvepharma EOOD | 1 |
| BiloVet | Bimeda Animal Health Limited | 1 |
| Paylean plus Tylovet | Huvepharma EOOD | 2 |
| Rumensin plus Tylovet 100 | Huvepharma EOOD | 2 |
| MGA plus Tylovet 100 | Huvepharma EOOD | 2 |
| Deccox, Rumensin, and Tylovet 100 | Huvepharma EOOD | 3 |
| MGA, Rumensin and Tylovet 100 | Huvepharma EOOD | 3 |
| MGA/ Bovatec/ Tylovet 100 | Huvepharma EOOD | 3 |
| Zilmax/Rumensin/Tylovet 100/MGA | Huvepharma EOOD | 4 |
| Zilmax/Rumensin/Tylovet 100 | Huvepharma EOOD | 3 |
| Engain plus Tylan | Zoetis Inc. | 2 |
| Actogain 45/Rumensin/Tylan | Zoetis Inc. | 3 |
| Actogain 45/Rumensin/Tylan/MGA | Zoetis Inc. | 4 |
| Optaflexx 45/Rumensin/Tylovet 100 | Huvepharma EOOD | 3 |
| Optaflexx 45/Rumensin/Tylovet 100/MGA | Huvepharma EOOD | 4 |
| Actogain 45/Rumensin/Tylovet 100/MGA | Zoetis Inc. | 4 |
| Engain plus Tylovet 100 | Zoetis Inc. | 2 |
| Actogain 45/Rumensin/Tylovet 100 | Zoetis Inc. | 3 |
| Monovet and Tylovet | Huvepharma EOOD | 2 |
| Monovet and Tylan | Huvepharma EOOD | 2 |
| Optaflexxand Monovet and Tylovet | Huvepharma EOOD | 3 |
| Actogain and Monovet and Tylovet | Huvepharma EOOD | 3 |
| Optaflexxand Monovet and Tylan | Huvepharma EOOD | 3 |
| Actogain and Monovet and Tylan | Huvepharma EOOD | 3 |
| Optaflexx and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| Actogain and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| Optaflexx and Monovet and Tylan and MGA | Huvepharma EOOD | 4 |
| Actogain and Monovet and Tylan and MGA | Huvepharma EOOD | 4 |
| Deccox and Monovet and Tylovet | Huvepharma EOOD | 3 |
| Deccox and Monovet and Tylan | Huvepharma EOOD | 3 |
| MGA and Monovet and Tylovet | Huvepharma EOOD | 3 |
| MGA and Monovet and Tylan | Huvepharma EOOD | 3 |
| Optigrid and Monovet and Tylovet | Huvepharma EOOD | 3 |
| Optigrid and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| CycleGuard and Monovet and Tylovet | Huvepharma EOOD | 3 |
| Optigrid and Monovet and Tylovet and CycleGuard | Huvepharma EOOD | 4 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:17658 | CHEBI |
| TYK | PDB_CHEM_ID |
| CHEMBL42743 | ChEMBL_ID |
| 13707 | IUPHAR_LIGAND_ID |
| DB11475 | DRUGBANK_ID |
| 373553006 | SNOMEDCT_US |
| 96020006 | SNOMEDCT_US |
| 96021005 | SNOMEDCT_US |
| 96022003 | SNOMEDCT_US |
| C0041441 | UMLSCUI |
| D015645 | MESH_DESCRIPTOR_UI |
| 2109 | INN_ID |
| 1405-53-4 | SECONDARY_CAS_RN |
| 74610-55-2 | SECONDARY_CAS_RN |
| D02490 | KEGG_DRUG |
| 5280440 | PUBCHEM_CID |
| NOCODE | MMSL |
| YEF4JXN031 | UNII |
| 1363719 | RXNORM |
Pharmaceutical products:
None